Physician profile
Barbara E Harper
NPI 1750452975
$1,203.27
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $598 · 2022: $415 · 2024: $191.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $191.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $190.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $185.89 | 2021-2022 | |
| Evofem Biosciences, INC. | $172.17 | 2021-2022 | |
| Agile Therapeutics, INC. | $115.20 | 2021 | |
| Astellas Pharma US INC | $102.91 | 2024 | Veozah |
| Bayer Healthcare Pharmaceuticals INC. | $87.72 | 2024 | |
| Organon LLC | $69.12 | 2021-2022 | |
| Pfizer INC. | $53.14 | 2021-2022 | |
| Exeltis, USA INC. | $50.88 | 2021-2022 | |
| Mayne Pharma Commercial LLC | $49.57 | 2021-2022 | |
| Therapeuticsmd, INC. | $48.90 | 2021-2022 | |
| Mylan Pharmaceuticals INC. | $47.51 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $41.22 | 2021 | |
| Scynexis, INC. | $33.69 | 2022 | |
| Avion Pharmaceuticals | $31.40 | 2021-2022 | |
| Hologic Sales and Service, LLC | $18.79 | 2022 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Millicent US INC | $18.57 | 2021 | |
| Coopersurgical, INC. | $16.85 | 2021 | |
| Amgen INC. | $15.55 | 2021 | |
| Lupin INC. | $15.09 | 2021 | |
| Novo Nordisk INC | $15.01 | 2021 | |
| Axonics, INC. | $14.09 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Barbara Harper listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.